Bloomberg -- An experimental drug made by Pfizer Inc. (PFE) slowed deadly pancreatic cancer in a study that revealed a new treatment approach that tricks the immune system to attack tissue protecting tumors, researchers said.
Bloomberg -- An experimental drug made by Pfizer Inc. (PFE) slowed deadly pancreatic cancer in a study that revealed a new treatment approach that tricks the immune system to attack tissue protecting tumors, researchers said.
